Detalhe da pesquisa
1.
Antitumor activity of cell-penetrant kinin B1 receptor antagonists in human triple-negative breast cancer cells.
J Cell Physiol
; 234(3): 2851-2865, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30132865
2.
Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuli.
J Cell Physiol
; 222(1): 168-76, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19780024
3.
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.
J Cell Physiol
; 216(1): 234-44, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-18264983
4.
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer.
Oncotarget
; 9(11): 9885-9906, 2018 Feb 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29515778
5.
Induction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat model.
PLoS One
; 7(5): e37485, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22629405
6.
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Neuropeptides
; 44(2): 177-85, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20080302
7.
Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor.
Peptides
; 30(4): 777-87, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19111586
8.
Novel kinin B1 receptor agonists with improved pharmacological profiles.
Peptides
; 30(4): 788-95, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19150636
9.
Valproate induces replication-independent active DNA demethylation.
J Biol Chem
; 278(30): 27586-92, 2003 Jul 25.
Artigo
Inglês
| MEDLINE | ID: mdl-12748177
10.
Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo.
Carcinogenesis
; 25(4): 499-507, 2004 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-14688029
11.
Antisense MBD2 gene therapy inhibits tumorigenesis.
J Gene Med
; 4(4): 381-9, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-12124980